Aviceda raises $207.5 million in Series C funding to advance geographic atrophy program
Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic atrophy, according to a press release.
Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic atrophy, according to a press release.
The findings could lead to a potential treatment for a common cause of blindness
Purpose To compare clinical outcomes of transepithelial photorefractive keratectomy (t-PRK) and conventional epithelium-off PRK (PRK) in patients with high compound myopic astigmatism. Methods Sixty eyes…
Learn about Glaucoma, Glaucoma signs and symptoms, and how to prevent blindness from Gluacoma
Wills Eye Resident Series : A patient presents with decreased vision after an injury , p. 62 medicare Q & A 2024 Reimbursement Update Wills…
To analyze endophthalmitis characteristics and risks following a 25-gauge vitrectomy or microincision vitrectomy surgery (MIVS).
In the past few years, accommodating IOLs (AccIOLs) have progressed through design, validation, and human trials with variable results. As surgeons, we must reexamine the fundamentals…
Infants with food protein-induced enterocolitis syndrome face risks for iron deficiency, with potential impacts on their growth, according to a study published in The Journal…
NEW YORK — In this presentation from OSN New York, Uday Devgan, MD, of Devgan Eye Surgery, uses surgical footage to demonstrate how to resolve…
Patients with asthma in South Korea faced increased risk for suicide compared with those who did not have asthma, according to a study published in…
Exposure to high nighttime aircraft noise was tied to cardiac remodeling consistent with changes associated with increased risk for major adverse cardiac events, researchers reported.A…